These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12115596)

  • 1. Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.
    Feleszko W; Młynarczuk I; Olszewska D; Jalili A; Grzela T; Lasek W; Hoser G; Korczak-Kowalska G; Jakóbisiak M
    Int J Cancer; 2002 Jul; 100(1):111-8. PubMed ID: 12115596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
    Feleszko W; Lasek W; Gołab J; Jakóbisiak M
    Neoplasma; 1995; 42(2):69-74. PubMed ID: 7617079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.
    Martirosyan A; Clendening JW; Goard CA; Penn LZ
    BMC Cancer; 2010 Mar; 10():103. PubMed ID: 20298590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models.
    Rozados VR; Hinrichsen LI; Binda MM; Gervasoni SI; Matar P; Bonfil RD; Scharovsky OG
    Oncol Rep; 2008 May; 19(5):1205-11. PubMed ID: 18425377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.
    Feleszko W; Zagozdzon R; Gołab J; Jakóbisiak M
    Eur J Cancer; 1998 Feb; 34(3):406-11. PubMed ID: 9640231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
    Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
    Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
    Dua P; Ingle A; Gude RP
    Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
    Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
    J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines.
    Feleszko W; Jalili A; Olszewska D; Mlynarczuk I; Grzela T; Giermasz A; Jakóbisiak M
    Oncol Rep; 2002; 9(4):879-85. PubMed ID: 12066226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
    Sora MK; Kruszewski AA; Stokłosa T; Czyzyk J; Lasek W; Malejczyk J; Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):269-74. PubMed ID: 7487365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
    Liu X; Chan SY; Ho PC
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):167-74. PubMed ID: 18465132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiabendazole, a well-known antifungal drug, exhibits anti-metastatic melanoma B16F10 activity via inhibiting VEGF expression and inducing apoptosis.
    Zhang J; Zhao C; Gao Y; Jiang Y; Liang H; Zhao G
    Pharmazie; 2013 Dec; 68(12):962-8. PubMed ID: 24400443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
    De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
    Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K; Kaminski R; Legat M; Kopec M; Nowis D; Skierski JS; Koronkiewicz M; Jakóbisiak M; Golab J
    Int J Oncol; 2004 May; 24(5):1149-57. PubMed ID: 15067336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
    Dabrowska-Iwanicka A; Olszewska D; Jalili A; Makowski M; Grzela T; Marczak M; Hoser G; Giermasz A; Golab J; Jakóbisiak M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):433-42. PubMed ID: 12200600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
    Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis.
    Feleszko W; Bałkowiec EZ; Sieberth E; Marczak M; Dabrowska A; Giermasz A; Czajka A; Jakóbisiak M
    Int J Cancer; 1999 May; 81(4):560-7. PubMed ID: 10225445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.